INSIGHT: Generics shortages could get way worse across Europe
When Ignasi Biosca-Reig heard there were generics shortages of amoxicillin in Spain, he quickly added shifts at his drug company's factories to boost production...
NICE recommends new ‘cost-effective’ migraine drug
National Institute for Health and Care Excellence (NICE) today recommended Teva’s migraine drug fremanezumab, sold under the brand name Ajovy, for NHS use.
The final...
Teva’s Andrew Ellis is new BBA chair
The British Biosimilars Association (BBA), the representative group of biosimilar manufacturers in the UK, today named Teva's Dr Andrew Ellis as its new chair.
He replaces...